Fernando, Pilar Gina E.
HRN: 21-23-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/20/2022
MUPIROCIN 2%, 15G (TUBE)
04/20/2022
04/26/2022
TOPICAL
15mg
BID
Infected Post-op Wound
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes